BMRN
Biomarin Pharm (BMRN)
NASDAQ
$56.65+$1.44 (+2.61%)
Price as of Oct 22, 2026 7:30 PM EDT
  • $10.7B
    Market Cap
  • 3.45%
    1-Year Change
  • Biotechnology
    Industry

Earnings Score

Score: 29
Valuation
BMRN
vs History
vs S&P 500
Profitability
-0
Growth
-0
Low Earnings Volatility
0

Momentum Score

Score: 41
Valuation
BMRN
vs History
vs S&P 500
3-Month Momentum
7.03%
12-Month Momentum
17.77%
3-Month Risk Adjusted Momentum
50.97%
12-Month Risk Adjusted Momentum
51.41%

True Yield

N/A
Valuation
BMRN
vs History
vs S&P 500
Dividend Yield
N/A
Net Buyback Yield
-0.06%
Net Debt Paydown Yield
-19.43%

Financial Health Score

Score: 0
Valuation
BMRN
vs History
vs S&P 500
Ohlson's O-Score
6